
Bioorganic and medicinal chemistry p. 6123 - 6133,11 (2012)
Update date:2022-08-03
Topics:
Tichy, Michal
Pohl, Radek
Hocek, Michal
Xu, Hao Ying
Chen, Yen-Liang
Yokokawa, Fumiaki
Shi, Pei-Yong
A series of new pyrimido[4,5-b]indole ribonucleosides bearing phenyl or hetaryl group at position 4 has been prepared by selective Pd-catalyzed cross-coupling reactions of the corresponding protected 4,6-dichloropyrimido[4, 5-b]indole ribonucleoside with (het)arylboronic acids or stannanes followed by deprotection. Further cross-couplings under harsher conditions and employing X-Phos ligand proceeded at the position 6 leading to 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides. Some of these compounds displayed antiviral activity against Dengue virus.
View MoreAnhui Gusheng Import&Export CO.,LTD
Contact:86-551-63662296
Address:Jinzhai Road NO.162 ,hefei, china
Hangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Nanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:0792-8228321
Address:10TH Floor No.121 binjiang Road Xunyang District
Doi:10.1021/acs.orglett.1c00133
(2021)Doi:10.1021/jo01155a006
(1949)Doi:10.1007/BF00945332
()Doi:10.1021/acs.orglett.8b02701
(2018)Doi:10.1007/BF00779074
()Doi:10.1021/ja037223k
(2003)